ReP USP - Resultado da busca

Filtros : "Fritch, Ethan J." "CUNHA, FERNANDO DE QUEIROZ" "FCFRP" Removidos: "FMRP-RIO" "Journal of Dental Research" Limpar

Filtros

USP affiliated authors
- alves filho, josé carlos farias (2)
- batah, sabrina setembre (2)
- cunha, fernando de queiroz (2)
- cunha, thiago mattar (2)
- damasceno, samara (2)

Indexado em
- indexado no scopus (~1)
Collaboration
Normalized affiliation
Non normalized affiliation
- center for integrative chemical biology and drug discovery, chemical biology and medicinal chemistry, eshelman school of pharmacy, university of north carolina, chapel hill, north carolina (1)
- collaborations pharmaceuticals, inc., 840 main campus drive, raleigh, north carolina (1)
- collaborations pharmaceuticals, inc., raleigh (1)
- collaborations pharmaceuticals, inc.,main campus drive, lab 3510, raleigh, north carolina (1)
- department of biological sciences, north carolina state university, raleigh, north carolina (1)

Artigo de periodico
Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice (2022)
Puhl, Ana C.; Gomes, Giovanni Freitas; Damasceno, Samara; Fritch, Ethan J.; Levi, James A.; Johnson, Nicole J.; Scholle, Frank; Premkumar, Lakshmanane; Hurst, Brett L.; Lee-Montiel, Felipe; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Moorman, Nathaniel J.; Yount, Boyd L.; Dickmander, Rebekah J.; Baric, Ralph S.; Pearce, Kenneth H.; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Source: ACS Omega. Unidades: FCFRP, FMRP
Subjects: CORONAVIRUS, CITOCINAS, ANTINEOPLÁSICOS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice. ACS Omega, v. 7, p. 31935-31944, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsomega.2c02794. Acesso em: 11 nov. 2024.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2022). Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice. ACS Omega, 7, 31935-31944. doi:10.1021/acsomega.2c02794
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, Lee-Montiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander RJ, Baric RS, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice [Internet]. ACS Omega. 2022 ; 7 31935-31944.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1021/acsomega.2c02794
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, Lee-Montiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander RJ, Baric RS, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice [Internet]. ACS Omega. 2022 ; 7 31935-31944.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1021/acsomega.2c02794
Artigo de periodico
Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice (2021)
Puhl, Ana C.; Gomes, Giovanni Freitas; Damasceno, Samara; Fritch, Ethan J.; Levi, James A.; Johnson, Nicole J.; Scholle, Frank; Premkumar, Lakshmanane; Hurst, Brett L.; LeeMontiel, Felipe; Veras, Flávio Protásio; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic; Moorman, Nathaniel J.; Yount, Boyd L.; Dickmander, Rebekah; Baric, Ralph; Pearce, Kenneth H.; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias; Cunha, Thiago Mattar; Ekins, Sean
Source: bioRxiv. Unidades: FCFRP, FMRP
Subjects: ANTIVIRAIS, ANTINEOPLÁSICOS, CITOCINAS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, p. 1-52, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.12.16.472155. Acesso em: 11 nov. 2024.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2021). Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, 1-52. doi:10.1101/2021.12.16.472155
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1101/2021.12.16.472155
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1101/2021.12.16.472155

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024